Your browser doesn't support javascript.
loading
Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process.
Jackson, Samuel J; Authier, Simon; Brohmann, Henning; Goody, Susan M G; Jones, David; Prior, Helen; Rosch, Anke; Traebert, Martin; Tse, Karen; Valentin, Jean Pierre; Milne, Aileen.
Afiliação
  • Jackson SJ; The National Centre for the Replacement, Refinement and Reduction of Animals in Research, Gibbs Building, 215 Euston Road, London NW1 2BE, United Kingdom. Electronic address: sam.jackson@nc3rs.org.uk.
  • Authier S; Citoxlab North America, 445 Boulevard Armand-Frappier, Laval, Quebec H7V 4B3, Canada. Electronic address: authiers@ca.citoxlab.com.
  • Brohmann H; Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany. Electronic address: Henning.Brohmann@bfarm.de.
  • Goody SMG; Pfizer, Inc., Eastern Point Road, Groton, CT 06340, United States. Electronic address: Susan.Goody@pfizer.com.
  • Jones D; Medical and Healthcare products Regulatory Agency, 10 South Colonnade, Canary Wharf, London E14 4PU, United Kingdom. Electronic address: David.Jones@mhra.gov.uk.
  • Prior H; The National Centre for the Replacement, Refinement and Reduction of Animals in Research, Gibbs Building, 215 Euston Road, London NW1 2BE, United Kingdom. Electronic address: helen.prior@nc3rs.org.uk.
  • Rosch A; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Baden Wurttemberg 88397, Germany.. Electronic address: anke.rosch@boehringer-ingelheim.com.
  • Traebert M; Novartis Institutes for Biomedical Research, Klybeckstrasse. 141, CH-4057 Basel, Switzerland. Electronic address: martin.traebert@novartis.com.
  • Tse K; AstraZeneca, R&D Biopharmaceuticals, Fleming Building (B623), Babraham Research Park, Babraham, Cambridgeshire CB22 3AT, United Kingdom. Electronic address: Karen.Tse@astrazeneca.com.
  • Valentin JP; UCB Biopharma SPRL, Chemin du Foriest, B-1420, Braine-l'Alleud, Belgium. Electronic address: Jean-Pierre.Valentin@ucb.com.
  • Milne A; Charles River, Tranent, Edinburgh EH33 2NE, United Kingdom. Electronic address: aileen.milne@crl.com.
J Pharmacol Toxicol Methods ; 100: 106602, 2019.
Article em En | MEDLINE | ID: mdl-31238094
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacologia / Modelos Animais / Avaliação Pré-Clínica de Medicamentos / Desenvolvimento de Medicamentos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Animals / Humans Idioma: En Revista: J Pharmacol Toxicol Methods Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacologia / Modelos Animais / Avaliação Pré-Clínica de Medicamentos / Desenvolvimento de Medicamentos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Animals / Humans Idioma: En Revista: J Pharmacol Toxicol Methods Ano de publicação: 2019 Tipo de documento: Article